AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-2.95 Cr | ₹9.09 Cr | ₹-19 Cr | ₹-5.84 Cr | ₹-14 Cr |
What is the latest Cash Flow from Financing Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-2.95 Cr |
Mar2023 | ₹9.09 Cr |
Mar2022 | ₹-19 Cr |
Mar2021 | ₹-5.84 Cr |
Mar2020 | ₹-14 Cr |
How is Cash Flow from Financing Activities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-2.95 Cr | Negative | |
Mar2023 | ₹9.09 Cr | Positive | |
Mar2022 | ₹-19 Cr | Negative | |
Mar2021 | ₹-5.84 Cr | Negative | |
Mar2020 | ₹-14 Cr | - |
Compare Cash Flow from Financing Activities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹283.6 Cr | 3.9% | 1.2% | -21% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,971.0 Cr | -4.6% | 0.7% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,153.0 Cr | -1.2% | 12.6% | 51.2% | Stock Analytics | |
CIPLA | ₹122,717.0 Cr | 0.7% | 6% | 9.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,392.0 Cr | -1.8% | -0.4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,702.0 Cr | 4% | 8.9% | -1.3% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | 3.9% |
1.2% |
-21% |
SENSEX | 0.6% |
11% |
10.4% |
You may also like the below Video Courses